#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neoplasm Ependymoma Plasma cell myeloma recurrent Hepato-lenticular degeneration Vascular malformation Uveitis Angiosarcoma Glomerulonephritis acute Renal cancer metastatic C3 glomerulopathy Tourette's disorder Central nervous system neoplasm Neuropathy peripheral Pseudomyxoma peritonei Renal disorder More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Primary immunodeficiency syndrome – Life with Disease Nephroblastoma Progressive multifocal leukoencephalopathy – Diagnostics Progressive multifocal leukoencephalopathy – Trials in Disease Testicular leiomyosarcoma – Life with Disease Mantle cell lymphoma refractory – Basic Information Ewing’s sarcoma recurrent – Treatment Gaucher’s disease type I – Treatment Thrombotic thrombocytopenic purpura More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ganciclovir Ly3437943 Sodium Tryptophan Esflurbiprofen Cytarabine Glutenin Bay 3283142 Ginisortamab Cx-044933 Indacaterol Loncastuximab Tesirine Apocynin Melphalan Tolvaptan Daunorubicin Hydrochloride Benzyl Alcohol Evx-01 Furosemide Delafloxacin Human Serum Albumin 5% More therapies…

    Learn about Your Condition

    Schizophreniform disorder Neurodevelopmental disorder Chronic hepatitis B Lumbosacral radiculopathy Rectal cancer stage III Perineal injury Leukoencephalopathy Behcet's syndrome Hereditary ataxia Agitation postoperative Exudative retinopathy Bile acid synthesis disorder Myxoid liposarcoma Post-traumatic headache Fibrosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Elebsiran
    • Tobevibart
    France Germany Romania

  • Study on the Safety and Effects of Baricitinib in People with HIV

    Not recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Baricitinib
    Spain

  • Study on the Effects and Safety of Ginkgo Biloba Extract in Patients with Cognitive Impairment After COVID-19

    Not recruiting

    2 1 1
    Germany Poland Spain

  • Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • GS-1720
    • Gs-4182
    • Bictegravir
    Germany Poland Portugal Romania Spain

  • Study on ITPP and Sodium Chloride for Patients with COVID-19 and Other Lung Infections Facing Breathing Problems

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Sodium Chloride
    Poland

  • Study of Long-Acting Cabotegravir and Rilpivirine for People Aged 60 and Over Living with HIV-1

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabotegravir
    • Rilpivirine
    Spain
Previous Page
1 … 33 34 35 36 37 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!